Latest Medicine stories from Life.
Strategic angle: “The volume of evidence behind a therapy has become inversely correlated with public trust in it,” writes Vikas Patel.
Strategic angle: A Supreme Court ruling this week on gender and sexuality 'conversion therapy' could narrow the authority of state medical boards over care involving speech.
Strategic angle: A new way to define obesity aims to sharpen the diagnosis. Critics warn it could delay care, exclude diabetes, and deepen inequities in accessing treatment.
Strategic angle: The daily pill called Foundayo got a fast track through the Food and Drug Administration.
Strategic angle: A delayed FDA decision for Orca Bio, new questions about pharma-telehealth tie-ups, and more
Strategic angle: A new study explores whether incorporating psychotherapy with ketamine treatment enhances its effectiveness.
Strategic angle: “Rigorously derived evidence for the medical efficacy of marijuana is thin,” writes Kevin Sabet.
Strategic angle: A breakthrough in the fight against superbugs and antimicrobial resistance.
Strategic angle: Drugmakers are postponing the release of new medicines in Europe due to shifting pricing policies and pressures from the U.S.
Strategic angle: Here’s Why Fresenius Medical Care AG (FMS) Remains Attractive
Strategic angle: Takeda Pharmaceuticals, the largest biopharma employer in Mass., will lay off 250 workers in Cambridge beginning in July.
Strategic angle: The organization criticized Gilead Sciences after months of negotiations for a limited supply of lenacapavir.
Strategic angle: The drug demonstrates improved skin clearance, marking a significant advancement in lupus treatment.
Strategic angle: The White House shares legislative text on drug pricing with major pharmaceutical companies.
Strategic angle: Levi Vargas, 30, faced a tragic incident while competing in the Baker to Vegas race amid extreme heat conditions.
Strategic angle: In February, TrumpRx joined a growing list of websites consumers can tap for discounts on their medicines. Here's a cheat sheet for getting the best deal.
Strategic angle: The White House is working to build support for drug pricing legislation, part of an election year focus on affordability.
Strategic angle: Amebiasis, caused by Entamoeba histolytica, affects millions globally, highlighting the need for innovative drug discovery methods.
A significant decision by the FDA following previous rejections of rare disease treatments.
Strategic angle: A new MRI method measures cardiac oxygen use in three minutes without catheters or radiation, offering a simpler way to study heart failure and metabolism.